The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Nazli Dizman
Stock and Other Ownership Interests - Several pharmaceutical companies (I)
Consulting or Advisory Role - Eisai
 
Rebecca Tidwell
No Relationships to Disclose
 
Rahul Sheth
Consulting or Advisory Role - Johnson & Johnson/Janssen; Medtronic; TriSalus Life Sciences
Speakers' Bureau - Boston Scientific
Research Funding - Boston Scientific
 
Omar Alhalabi
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bicycle Therapeutics; Cardinal Health; Seagen; Silverback Therapeutics
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Genentech (Inst); Ikena Oncology (Inst)
 
Paul Corn
Research Funding - Janssen Oncology (Inst)
 
Matthew Campbell
Honoraria - Curio Science; Eisai; Eisai; Exelixis; Merck; MJH Life Sciences; OnViv; Pfizer; Targeted Oncology
Research Funding - Exelixis (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - Exelixis; SeaGen
 
Sangeeta Goswami
No Relationships to Disclose
 
Andrew Johns
Stock and Other Ownership Interests - Lilly; Merck; Stryker
 
Eric Jonasch
Consulting or Advisory Role - Arcus Biosciences; Aveo; Eisai; Exelixis; GlaxoSmithKline; Ipsen; Merck; NiKang Therapeutics; Novartis; Takeda; Telix Pharmaceuticals
Research Funding - Abbvie (Inst); Aveo (Inst); Bristol Myers Squibb Foundation (Inst); Corvus Pharmaceuticals (Inst); Merck (Inst); NiKang Therapeutics (Inst); ProfoundBio (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Pfizer
 
John Lin
No Relationships to Disclose
 
Amishi Shah
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Exelixis; Pfizer/EMD Serono
Research Funding - 4D Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); EMD Serono (Inst)
 
Jianbo Wang
No Relationships to Disclose
 
Amado Zurita
Consulting or Advisory Role - Bayer; Dendreon; Exelixis; Hikma Pharmaceuticals; Janssen Oncology; Pfizer/Astellas
Speakers' Bureau - CancerNet; Hikma Pharmaceuticals; Janssen Oncology; McKesson
Research Funding - ABX Advanced biochemical compounds; Clarity Pharmaceuticals; Fusion Pharmaceuticals; Merck; Pfizer/Astellas
Travel, Accommodations, Expenses - Hikma Pharmaceuticals
 
Jianjun Gao
Research Funding - Summit Therapeutics
 
Nizar Tannir
Stock and Other Ownership Interests - Amgen; BioCryst; Johnson & Johnson/Janssen; Spdr S&P Pharmaceuticals ETF; Surface Oncology; Vanguard Health Care
Honoraria - Bristol-Myers Squibb; Eisai; Intellisphere; Ipsen; Merck Sharp & Dohme; Oncorena
Research Funding - Arrowhead Pharmaceuticals Inc. (Inst); Bristol Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Nektar (Inst); Novartis (Inst)
 
Andrew Hahn
Honoraria - Binacea; Curio Science; Dava Oncology; IDEOlogy Health; Kaplan Partners in Knowledge; Mashup Media; Medscape; MJH Life Sciences
Consulting or Advisory Role - AVEO; Eisai; Exelixis; Intellisphere; Janssen Scientific Affairs; Pfizer; Tolmar
Research Funding - Bayer; Bristol Myers Squibb; Eisai (Inst); Halda Therapeutics
Travel, Accommodations, Expenses - Dava Oncology
 
Pavlos Msaouel
Honoraria - Exelixis; Mirati Therapeutics; Pfizer
Consulting or Advisory Role - Axiom Healthcare Strategies
Research Funding - Bristol-Myers Squibb (Inst); Gateway for Cancer Research (Inst); Mirati Therapeutics (Inst); Summit Therapeutics; Takeda (Inst)